Drugs / CMS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03093974 | Jun 2017 → Apr 2021 | bronchiectasis | Zambon SpA | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03093974 ↗ |
| Route | Inhaled | “for administration by inhalation” NCT03093974 ↗ |